Figure 1.
Figure 1. OS according to whether patients were rituximab sensitive, rituximab refractory or had not received rituximab before ASCT

OS according to whether patients were rituximab sensitive, rituximab refractory or had not received rituximab before ASCT

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal